Management

Management Team

BioGenCell is led by a team of seasoned executives who have many years of executive and technical experience in the biotechnology industry. The founding team has a proven track record in the creation and manufacturing of commercially available cellular products, which were proven safe and beneficial for treating severe heart diseases and peripheral arterial diseases.
Yael Porat, PHD

Yael Porat, PHD

CEO, FOUNDER​

Dr. Porat is a specialist in the biotechnology industry, having worked as an innovator, scientist, advisor and director for both industry leaders and pioneering startups.

Read More
Prof. Michael Belkin, MD​

Prof. Michael Belkin, MD​

CHIEF SCIENTIFIC OFFICER, CO-FOUNDER

Prof. Belkin has been involved in biotechnology ventures since the creation of the field and was involved in the establishment of over 15 medical start-ups in ophthalmology and other fields

Read More
Mr. Eyal Peleg, CPA, MBA

Mr. Eyal Peleg, CPA, MBA

CHIEF FINANCIAL OFFICER, CO-FOUNDER

Mr. Peleg has over 25 years experience in growing and managing professional teams as a CEO. He is currently a consultant to both start-ups and established companies on the issues of strategic planning,

Read More
Marc Dechamps

Marc Dechamps

BIOGENCELL EU ADMINISTRATOR

Marc Dechamps is a biologist with extensive experience of more than 30 years in the Pharmaceutical industry, with expertise in market development for new products including infectious diseases, immunological disorders, cancer, CNS diseases and vaccines.

Read More
Michael Barnea, Adv

Michael Barnea, Adv

LEGAL ADVISOR

Mr. Barnea is a senior partner at the law firm of Barnea & Co., where he specializes in technology-related sales, licensing and development transactions, and has advised technology...

Read More
Dr. Peter Stangier

Dr. Peter Stangier

STRATEGIC PLANNING AND BD

Dr. Stangier is partner at ACCELERO Gmbh, founder and Managing Director of ‘From Data To Decisions’ since 2013. Dr. Stangier is knowledgeable strategic planner with over 20 years of experience who has worked for Big Pharma in mass markets to medium size and start up biotech companies. 

Read More

Dr. Yael Porat, PHD

CEO, Founder

Dr. Porat is a specialist in the biotechnology industry, having worked as an innovator, scientist, advisor and director for both industry leaders and pioneering startups.

Prof. Michael Belkin, MD

Chief Scientific Officer, Co-Founder

Prof. Belkin has been involved in biotechnology ventures since the creation of the field and was involved in the establishment of over 15 medical start-ups in ophthalmology and other fields 

Mr. Eyal Peleg, CPA, MBA

Co-Founder, CHIEF FINANCIAL officer

Mr. Peleg has over 25 years experience in growing and managing professional teams as a CEO. He is currently a consultant to both start-ups and established companies on the issues of strategic planning,

Marc Dechamps

BioGenCell EU Administrator

Marc Dechamps is a biologist with extensive experience of more than 30 years in the Pharmaceutical industry, with expertise in market development for new products including infectious diseases, immunological disorders, cancer, CNS diseases and vaccines.  

Michael Barnea, Adv

Legal Advisor

Mr. Barnea is a senior partner at the law firm of Barnea & Co., where he specializes in technology-related sales, licensing and development transactions, and has advised technology..

Dr. Peter Stangier

Strategic Planning and BD

Dr. Stangier is partner at ACCELERO Gmbh, founder and Managing Director of ‘From Data To Decisions’ since 2013. Dr. Stangier is knowledgeable strategic planner with over 20 years of experience who has worked for Big Pharma in mass markets to medium size and start up biotech companies. 

Skip to content